FUROSEMIDE 20 MG + SPIRONOLACTONE 50
CMS-WAT-MEDICAL/ECOR · Pharmaceuticals · open
Key facts
- Published: 06 Aug 2026
- Closing date: 15 Sep 2026
- Status: open
Description
Tender for supply of FUROSEMIDE 20 MG + SPIRONOLACTONE 50 MG tablets, issued by CMS-WAT-MEDICAL/ECOR, with a closing date of 15/09/2026, under limited tender type, for procurement of medicines.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
- Documents required: approved letter of the Railway Board and its approved product list
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Single Packet
- Evaluation: Itemwise/Consigneewise
- Make in India (MII): No
- MSE preference: No
Line items (1)
- FUROSEMIDE 20 MG + SPIRONOLACTONE 50 MG TAB — Qty: 4500 Numbers
2 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals